Immediate Versus Early Endovenous Ablation In Venous Ulcer

NCT ID: NCT03795064

Last Updated: 2024-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-05

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is conducted to assess the effects of immediately started foam sclerotherapy in venous ulcer compared to early intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recently EVRA study showed that early endovenous ablation (foam sclerotherapy and/or endothermal ablation) is beneficial for venous ulcer healing. This randomized controlled trial is conducted to assess the effects of immediate foam sclerotherapy in the first visit to vascular outpatient clinic (immediate intervention). Patients in control group will receive foam sclerotherapy at four weeks (early intervention). Endothermal ablation is performed in early setting in both groups when truncal vein anatomy is suitable. The primary outcome for this study is the reduction of venous ulcer area at four weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate Intervention

Patients in this group will be treated with foam sclerotherapy immediately in the first visit to outpatient clinic (immediate intervention).

Group Type EXPERIMENTAL

Foam sclerotherapy

Intervention Type PROCEDURE

Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.

Endothermal ablation

Intervention Type PROCEDURE

Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.

Early Intervention

Patients in this group will be treated with foam sclerotherapy in the following visit to outpatient clinic at four weeks (early intervention).

Group Type ACTIVE_COMPARATOR

Foam sclerotherapy

Intervention Type PROCEDURE

Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.

Endothermal ablation

Intervention Type PROCEDURE

Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Foam sclerotherapy

Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.

Intervention Type PROCEDURE

Endothermal ablation

Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Venous ulcer \> 1 month
* Ulcer area \> 1cm2
* Palpable distal pulses / Ankle-brachial index \> 0,8 / Toe-brachial index \> 70mmhg (at least one criteria must be met)

Exclusion Criteria

* Leg ulcers other than venous etiology
* Pregnancy
* General contraindications for foam sclerotherapy
* Ulcers requiring operation theater revision
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oulu University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Toni Pihlaja

Vascular Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oulu University Hospital, Vascular Department

Oulu, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

References

Explore related publications, articles, or registry entries linked to this study.

Pihlaja T, Ohtonen P, Romsi P, Pokela M. Sub-ulcer foam sclerotherapy in patients with venous ulceration: A randomized controlled trial. Phlebology. 2025 Jun;40(5):324-329. doi: 10.1177/02683555241304030. Epub 2024 Nov 27.

Reference Type DERIVED
PMID: 39601296 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

268/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EVLA and Optimal Timing of Sclerotherapy
NCT04774939 NOT_YET_RECRUITING NA